The AUROC for discriminating pCR within the tumor compartment was 0.85 (95% CI 0.63–1.00) for CD11c+ (macrophage and DCs), 0.76 (95% CI 0.53–0.99) for CD11c+/MHCII+/CD163–/CD68– (DCs), 0.80 (95% CI 0.54–1.00) for CD11c+/MHCII–/CD163–/CD68– (nonactivated/immature DCs), and 0.77 (95% CI 0.55–0.99) for CD11c+/CD163+ (M2 macrophage; Table 1). This evidence concerns the gene CD163 and neoplasm.